CorestemChemon Inc.

CorestemChemon Inc.

생명공학 연구

Gyeonggi-do Seongnam-si 팔로워 56명

We strive for continuous innovation and progress as a global biotech company.

소개

CorestemChemon is a global biotechnology corporation centered on stem cell-based new drug development and non-clinical research divisions. Motivated by the urgent need for medication for patients, the bio-pharmaceuticals division remains dedicated to research and development. In 2014, the unit successfully commercialized Neuronata-R inj, a stem cell therapy for the rare disease Amyotrophic Lateral Sclerosis (ALS), making it the fifth stem cell therapy approved for use globally. Alongside ALS treatment, the division has pipelines for various diseases such as lupus, Neuromyelitis Optica (NMO), and multiple system atrophy (MSA). Leveraging the success of the ALS stem cell therapy, the unit plans to concentrate on developing treatments for rare and incurable neurological and autoimmune diseases to dominate new market.

업계
생명공학 연구
회사 규모
직원 201-500명
본사
Gyeonggi-do Seongnam-si
유형
상장기업
설립
2003
전문 분야
Biotechnology, Mesenchymal stem cell, ALS, Amyotrophic Lateral Sclerosis, Neurodegenerative disease,, Autoimmune disease 및 Personalized stem cell therapy

위치

  • 기본

    KR 24, Pangyo-ro 255beon-gil

    2F

    KR Gyeonggi-do Seongnam-si

    길 보기
  • 1952 Gallows Rd

    Suite 110

    US Virginia Vienna 22182

    길 보기

CorestemChemon Inc. 직원

업데이트

관련 페이지

비슷한 페이지